These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11517998)

  • 1. The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study.
    Giladi N; Gurevich T; Shabtai H; Paleacu D; Simon ES
    J Neurol; 2001 Jul; 248(7):572-6. PubMed ID: 11517998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type B for gait freezing in Parkinson's disease.
    Fernandez HH; Lannon MC; Trieschmann ME; Friedman JH
    Med Sci Monit; 2004 Jul; 10(7):CR282-4. PubMed ID: 15232500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin injections do not improve freezing of gait in Parkinson disease.
    Wieler M; Camicioli R; Jones CA; Martin WR
    Neurology; 2005 Aug; 65(4):626-8. PubMed ID: 16116132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease: a double blind placebo-controlled pilot study.
    Gurevich T; Peretz C; Moore O; Weizmann N; Giladi N
    Mov Disord; 2007 Apr; 22(6):880-3. PubMed ID: 17290455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin treatment of freezing of gait in Parkinson's disease patients as reflected in functional magnetic resonance imaging of leg movement.
    Vastik M; Hok P; Hlustik P; Otruba P; Tüdös Z; Kanovsky P
    Neuro Endocrinol Lett; 2016; 37(2):147-53. PubMed ID: 27179579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical treatment of freezing of gait.
    Giladi N
    Mov Disord; 2008; 23 Suppl 2():S482-8. PubMed ID: 18668620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incobotulinum toxin A in Parkinson's disease with foot dystonia: A double blind randomized trial.
    Rieu I; Degos B; Castelnovo G; Vial C; Durand E; Pereira B; Simonetta-Moreau M; Sangla S; Fluchère F; Guehl D; Burbaud P; Geny C; Gayraud D; Ory-Magne F; Bouhour F; Llinares E; Derost P; Marques A; Durif F
    Parkinsonism Relat Disord; 2018 Jan; 46():9-15. PubMed ID: 29102441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
    Pullman SL; Greene P; Fahn S; Pedersen SF
    Arch Neurol; 1996 Jul; 53(7):617-24. PubMed ID: 8929169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of botulinum toxin injection on length and force of the rectus femoris and triceps surae muscles during locomotion in patients with chronic hemiparesis (FOLOTOX).
    Supiot A; Geiger M; Bensmail D; Aegerter P; Pradon D; Roche N
    BMC Neurol; 2018 Aug; 18(1):104. PubMed ID: 30068305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin-B injection into the lacrimal gland and posterior cricoarytenoid muscle for the treatment of epiphora and abductor spasmodic dysphonia secondary to Parkinson's disease.
    Sachdev A; Costello D; Madge S
    Orbit; 2019 Jun; 38(3):248-251. PubMed ID: 29939826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Freezing of gait in patients with advanced Parkinson's disease.
    Giladi N; Treves TA; Simon ES; Shabtai H; Orlov Y; Kandinov B; Paleacu D; Korczyn AD
    J Neural Transm (Vienna); 2001; 108(1):53-61. PubMed ID: 11261746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
    Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose botulinum toxin with short-term electrical stimulation in poststroke spastic drop foot: a preliminary study.
    Bayram S; Sivrioglu K; Karli N; Ozcan O
    Am J Phys Med Rehabil; 2006 Jan; 85(1):75-81. PubMed ID: 16357552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism.
    Bruno VA; Fox SH; Mancini D; Miyasaki JM
    Can J Neurol Sci; 2016 Sep; 43(5):697-702. PubMed ID: 27514242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amantadine for freezing of gait in patients with Parkinson disease.
    Malkani R; Zadikoff C; Melen O; Videnovic A; Borushko E; Simuni T
    Clin Neuropharmacol; 2012; 35(6):266-8. PubMed ID: 23123688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum Toxin Treatment of Motor Disorders in Parkinson Disease-A Systematic Review.
    Jabbari B; Comtesse SM
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of endoscopic injection of botulinum toxin in elderly achalasic patients with tortuous megaesophagus or epiphrenic diverticulum.
    Wehrmann T; Kokabpick H; Jacobi V; Seifert H; Lembcke B; Caspary WF
    Endoscopy; 1999 Jun; 31(5):352-8. PubMed ID: 10433043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
    Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M
    Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns and predictors of freezing of gait improvement following rasagiline therapy: A pilot study.
    Rahimi F; Roberts AC; Jog M
    Clin Neurol Neurosurg; 2016 Nov; 150():117-124. PubMed ID: 27618783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.